News und Analysen
Verimatrix Application Shielding Technologies Honored in 2021 Global Infosec Awards
Regulatory News:
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced its recognition by Cyber Defense Magazine as a
Transgene and BioInvent Receive IND Approval from the U.S. FDA for BT-001, a Novel Oncolytic Virus for the Treatment of Solid Tumors
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and BioInvent International AB (“BioInvent”)
Prodways Group's Futur3D project is selected as a winner of the "Stimulus plan for the industrial sector" and receives a EUR 3.3 million grant
Prodways Group has been selected by the French government as one of the winners of the " Stimulus plan for the industrial sector " and has been awarded a €3.3 million grant. This support is part of
Groupe Gorgé's Futur3D project is selected as a winner of the "Stimulus plan for the industrial sector" and receives a EUR 3.3 million grant
Groupe Gorgé, through its subsidiary Prodways Group, has been selected by the French government as one of the winners of the " Stimulus plan for the industrial sector " and has been awarded a €3.3
NANOBIOTIX to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference
Regulatory News:
NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities
Transgene: Combined General Meeting of May 26, 2021
Regulatory News:
The Combined Ordinary and Extraordinary General Meeting of Transgene’s (Paris:TNG) shareholders was held today (May 26, 2021) at 10:00 a.m. at the Company's headquarters (400
ROBERTET : ECOM FOOD INDUSTRIES ACQUIRING
Robertet SA
37 Avenue Sidi Brahim 06130 Grasse – France
Société anonyme au capital de 5 754 612 € Rcs Grasse B 415 750 660
26 May 2021
Robertet is pleased to announce that they have acquired Ecom
Verimatrix tritt der Initiative AWS für Medien und Unterhaltung bei
Verimatrix, (Paris:VMX), ein führender Anbieter von kundenorientierten Sicherheitslösungen für die moderne vernetzte Welt, meldete heute, die Initiative AWS für Medien und Unterhaltung von Amazon
Nanobiotix Announces the Appointment of Dr. Gary Phillips as Chairman of the Nanobiotix Supervisory Board
Regulatory News:
NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities
Verimatrix Joins AWS for Media & Entertainment Initiative
Regulatory News:
Verimatrix, (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced its support for the AWS for Media & Entertainment
Artmarket.com: real paintings by blue-chip artists remain the super-stars of the art market, says Artprice
The Art Market seemed to have forgotten its past and all of its reference points after the online sale of Beeple's NFT Everydays (which sold for $69 million at the beginning of March). But the major
Paragon ID : Paragon ID acquires a controlling interest in Apitrak, reinforcing its leadership in Asset Tracking and Real-Time Location Systems
Paragon ID (Euronext Paris - FR0013318813 - PID), leading provider of identification solutions for Transport & Smart Cities, e-ID, Traceability, Brand Protection and Payment, announces its
CORRECTING and REPLACING Nanobiotix Announces Updated Results From Priority Pathways in Head and Neck Cancer and Immunotherapy for Potential First-in-class Radioenhancer NBTXR3 at 2021 Annual Meeting of the American Society for Clinical Oncology
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210519005957/en/
Please replace the release dated May 19, 2021 with
Quantum Genomics Announces the Publication of New Scientific Article in Biomedecine et Pharmacotherapy which further strengthen its Phase III development plan in difficult to treat and resistant hypertension
Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat difficult to
CBO TERRITORIA : Marie Caze residential district in Saint-Paul, a commercially successful intermediate-rent property development
Marie Caze residential district in Saint-Paul, a commercially successful intermediate-rent property development
-
Delivery of the Les Damiers 1 prestige residence already 100% sold
-
Delivery in
Bentley und ESI Group arbeiten gemeinsam an Weiterentwicklung des Flying Spur mittels nachhaltigen Designprozesses
Regulatorische Meldungen:
ESI Group (Paris:ESI), ein Global Player im Bereich Virtual Prototyping für die Industrie, arbeitete Hand in Hand mit Bentley an der Optimierung einer der besten
ABEO : Uptrend continues in ABEO's Sports and Changing Room divisions in Q4 2020/21
ABEO, a world leader in spots and leisure equipment today announces its revenue and order intake for the financial year ended 31 March 2021 (12 months).
€m Unaudited 2020/2021 2019/2020
Bentley and ESI Group Work Together to Refine the Flying Spur Through Sustainable Design Process
Regulatory News:
ESI Group (Paris:ESI), a global player in virtual prototyping for industries, worked hand in hand with Bentley on the optimization of one of the world’s finest four door sedan,
GROUPE BOGART : Q1 turnover: EUR 48.5 million (down 9.9%) - Significant revenues and EBITDA growth expected in 2021 despite forced closures early in the year
PRESS RELEASE
Paris, 17 May 2021
In the first quarter of 2021, Bogart Group posted consolidated turnover of €48.5 million, down 9.9% from €53.8 million in the first quarter of 2020. Turnover was
Nanobiotix to Present at the UBS Global Healthcare Virtual Conference
Regulatory News:
NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities
OL GROUPE : REVENUE FOR THE FIRST NINE MONTHS OF 2020/21
BUSINESS ACTIVITIES STILL SEVERELY AFFECTED BY THE DIRECT AND INDIRECT EFFECTS OF THE PANDEMIC
TOTAL REVENUE[1]: €150.0M (DOWN €115.7M VS. 9M 2019/20)
DIRECT AND INDIRECT PANDEMIC EFFECTS
HEXAOM (ex MFC) : HEXAOM - Q1 REVENUE: UP +17.8% TO EUR 230.6 MILLION
EXCELLENT SALES MOMENTUM
Consolidated (€M) unaudited Q1 2021 2020 % Change Revenue 230.6 195.8 +17.8% Of which Home Building 179.2 160.9 +11.4% Of
AUBAY : AVAILABILITY OF THE 2020 ANNUAL REPORT
Aubay announces the publication of its 2020 Annual Report.
The 2020 Annual Report is a free translation of selected sections of a reproduction of the official French version of the the “Document
NANOBIOTIX Partners With LianBio to Develop and Commercialize Potential First-in-Class Radioenhancer NBTXR3 Across Tumor Types and Therapeutic Combinations in China and Other Asian Markets
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210511006169/en/
NANOBIOTIX (Euronext : NANO – NASDAQ: NBTX), a